Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
about
SH3 domain of c-Src governs its dynamics at focal adhesions and the cell membrane.Specific-mutational patterns of p53 gene in bladder transitional cell carcinoma among a group of Iraqi patients exposed to war environmental hazards.Expression profiling for bladder cancer: strategies to uncover prognostic factors.Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies.Molecular staging of bladder cancer.Urothelial tumorigenesis: a tale of divergent pathways.Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics.Molecular markers for bladder cancer: the road to a multimarker approach.Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors.ARTD1 regulates cyclin E expression and consequently cell-cycle re-entry and G1/S progression in T24 bladder carcinoma cells.Molecular alterations associated with bladder cancer initiation and progression.Molecular abnormalities in Ewing's sarcoma.Modeling a lethal prostate cancer variant with small-cell carcinoma features.Prognostic value of cell-cycle regulation biomarkers in bladder cancer.RB1 in cancer: different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis.Downregulation of telomerase activity by diclofenac and curcumin is associated with cell cycle arrest and induction of apoptosis in colon cancer.Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma.Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers.Development of an optimal antigen retrieval protocol for immunohistochemistry of retinoblastoma protein (pRB) in formalin fixed, paraffin sections based on comparison of different methods.Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT.Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas.Trilateral retinoblastoma in a patient with Peutz-Jeghers syndrome.Patient derived organoids to model rare prostate cancer phenotypes.XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies
P2860
Q30009127-5A46F511-F1CB-4002-B69D-1CE7B930A000Q34396704-87F18F3E-312C-4510-B7D3-ED7656D4D9F6Q34537170-5D7721CC-8641-4EA4-BCFD-9B31D822B6A2Q34585359-C7156A67-9414-4AA4-9245-CAC86CFBD059Q36061127-547A18ED-4D93-467C-A2A7-1C3A2B25A7E5Q36166384-DB3ADB64-ED94-435A-A069-F02E8F4AED39Q36234720-429FB270-1D7C-43D6-960A-B8337B58CF86Q36395100-0E2C82B7-D097-4FDB-AE60-DD917FBC2D91Q36537788-FAFF75C3-C602-408C-961E-EDE8CE4626CEQ37025942-2D6124DD-0AE3-4ECB-AAFC-0B5070EC24B3Q37116089-0B0752A2-704B-4731-8358-DE1EDE554F05Q37143195-078281C2-4F90-410B-98EA-A16FA9994C69Q37279001-9034FE31-0FCB-46EB-AEC2-6BACA89F9EE6Q37300040-FB25914E-7A61-40D3-82AB-E2F723EA1570Q37582049-01B9E33A-1B20-4872-AC0C-FE0CB6883549Q38049692-7E5EC019-79BA-46E2-9888-FF659F347163Q38077510-F00F579A-38BE-4D52-AA51-3E5F7BF7DAA7Q38903062-B035E79A-481D-486D-9873-81D671E4C20BQ39044979-330E8A38-D0DF-4637-B13F-A408A97245C7Q39051337-6B7EDBB5-D834-4A86-8C9C-D5906B075B5FQ40032012-3EA4896A-D2FC-43ED-B1C3-A13634D7637AQ40126904-FFB42095-9B45-435C-8821-07901FAE625DQ40656134-8CA7C0DA-2EBE-4A87-B773-912B725C6E26Q54445947-A394B6CF-DCF4-4B74-9AB5-270F0889BBC4Q55367999-7F0795D3-FB70-4270-8716-8AA8803491DEQ57818336-ADC84F66-AF8D-4168-AB04-3654B7AC2751
P2860
Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Hyperphosphorylation of pRb: a ...... nactivation in bladder cancer.
@en
Hyperphosphorylation of pRb: a ...... nactivation in bladder cancer.
@nl
type
label
Hyperphosphorylation of pRb: a ...... nactivation in bladder cancer.
@en
Hyperphosphorylation of pRb: a ...... nactivation in bladder cancer.
@nl
prefLabel
Hyperphosphorylation of pRb: a ...... nactivation in bladder cancer.
@en
Hyperphosphorylation of pRb: a ...... nactivation in bladder cancer.
@nl
P2093
P356
P1476
Hyperphosphorylation of pRb: a ...... nactivation in bladder cancer.
@en
P2093
Ben George
Carlos Cordon-Cardo
Mohammad Alavi-Tafreshi
Peter A Jones
Peter J Goebell
Ram H Datar
Richard J Cote
Shan-Rong Shi
Sunanda J Chatterjee
Yuen Kai Fung
P304
P356
10.1002/PATH.1567
P577
2004-07-01T00:00:00Z